Teva rejected by U.S. high court justice on Copaxone patent

A board to discuss the Multiple Sclerosis modifying drug Copaxone

Teva rejected by U.S. high court justice on Copaxone patent

Postby MSUK » Thu Nov 14, 2013 3:19 am

Pharmaceutical Industries Ltd.’s Copaxone multiple-sclerosis drug to generic competition in May.

The lower court ruling invalidated one of the company’s patents and shaved more than a year off the legal protection for Copaxone, a treatment that generated $2.25 billion in U.S. sales for Teva in 2011. Chief Justice John Roberts today rejected Teva’s request to put that ruling on hold while the court decides whether to take up Teva’s appeal...... Read More - http://www.ms-uk.org/copaxone
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2180
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Copaxone

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service